SUBSCRIBE
SUBSCRIBE

Humanetics

IN THE PRESS
Drug Development
Safety and Cognitive Stability Are Key Findings in Phase IIA Trial of New Alzheimer’s Disease Treatment from Humanetics
July 13, 2009
 · 
1 min read
Drug Development
Humanetics Completes Phase I Safety and Pharmacokinetic Trial for New Radiation Countermeasure
January 11, 2008
 · 
1 min read
BioMidwest
Humanetics Receives $3.8 Million from U.S. Department of Defense to Continue Development of Medical Radiation Countermeasures
November 16, 2007
 · 
1 min read
BioMidwest
Humanetics Receives Orphan Drug Designation for Its BIO 300 Radiation Countermeasure
July 20, 2007
 · 
1 min read
Drug Development
FDA Clears Humanetics’ IND Filing To Commence Clinical Studies On New Radiation Countermeasure
January 11, 2007
 · 
1 min read
Drug Development
Humanetics Corporation And Mount Sinai School of Medicine To Begin Clinical Trials Of New Alzheimer’s Compound
March 30, 2006
 · 
1 min read
Load More
JOBS